Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFII

Mechanisms underlying the vein development remain largely unknown. Tie2 signaling mediates endothelial cell (EC) survival and vascular maturation and its activating mutations are linked to venous malformations. Here we show that vein formation are disrupted in mouse skin and mesentery when Tie2 sign...

Full description

Bibliographic Details
Main Authors: Man Chu, Taotao Li, Bin Shen, Xudong Cao, Haoyu Zhong, Luqing Zhang, Fei Zhou, Wenjuan Ma, Haijuan Jiang, Pancheng Xie, Zhengzheng Liu, Ningzheng Dong, Ying Xu, Yun Zhao, Guoqiang Xu, Peirong Lu, Jincai Luo, Qingyu Wu, Kari Alitalo, Gou Young Koh, Ralf H Adams, Yulong He
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2016-12-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/21032
id doaj-cfed42cfba284d59971714d7bf2ff36f
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Man Chu
Taotao Li
Bin Shen
Xudong Cao
Haoyu Zhong
Luqing Zhang
Fei Zhou
Wenjuan Ma
Haijuan Jiang
Pancheng Xie
Zhengzheng Liu
Ningzheng Dong
Ying Xu
Yun Zhao
Guoqiang Xu
Peirong Lu
Jincai Luo
Qingyu Wu
Kari Alitalo
Gou Young Koh
Ralf H Adams
Yulong He
spellingShingle Man Chu
Taotao Li
Bin Shen
Xudong Cao
Haoyu Zhong
Luqing Zhang
Fei Zhou
Wenjuan Ma
Haijuan Jiang
Pancheng Xie
Zhengzheng Liu
Ningzheng Dong
Ying Xu
Yun Zhao
Guoqiang Xu
Peirong Lu
Jincai Luo
Qingyu Wu
Kari Alitalo
Gou Young Koh
Ralf H Adams
Yulong He
Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFII
eLife
Tie2
COUP-TFII
vein specification
author_facet Man Chu
Taotao Li
Bin Shen
Xudong Cao
Haoyu Zhong
Luqing Zhang
Fei Zhou
Wenjuan Ma
Haijuan Jiang
Pancheng Xie
Zhengzheng Liu
Ningzheng Dong
Ying Xu
Yun Zhao
Guoqiang Xu
Peirong Lu
Jincai Luo
Qingyu Wu
Kari Alitalo
Gou Young Koh
Ralf H Adams
Yulong He
author_sort Man Chu
title Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFII
title_short Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFII
title_full Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFII
title_fullStr Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFII
title_full_unstemmed Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFII
title_sort angiopoietin receptor tie2 is required for vein specification and maintenance via regulating coup-tfii
publisher eLife Sciences Publications Ltd
series eLife
issn 2050-084X
publishDate 2016-12-01
description Mechanisms underlying the vein development remain largely unknown. Tie2 signaling mediates endothelial cell (EC) survival and vascular maturation and its activating mutations are linked to venous malformations. Here we show that vein formation are disrupted in mouse skin and mesentery when Tie2 signals are diminished by targeted deletion of Tek either ubiquitously or specifically in embryonic ECs. Postnatal Tie2 attenuation resulted in the degeneration of newly formed veins followed by the formation of haemangioma-like vascular tufts in retina and venous tortuosity. Mechanistically, Tie2 insufficiency compromised venous EC identity, as indicated by a significant decrease of COUP-TFII protein level, a key regulator in venogenesis. Consistently, angiopoietin-1 stimulation increased COUP-TFII in cultured ECs, while Tie2 knockdown or blockade of Tie2 downstream PI3K/Akt pathway reduced COUP-TFII which could be reverted by the proteasome inhibition. Together, our results imply that Tie2 is essential for venous specification and maintenance via Akt mediated stabilization of COUP-TFII.
topic Tie2
COUP-TFII
vein specification
url https://elifesciences.org/articles/21032
work_keys_str_mv AT manchu angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT taotaoli angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT binshen angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT xudongcao angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT haoyuzhong angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT luqingzhang angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT feizhou angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT wenjuanma angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT haijuanjiang angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT panchengxie angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT zhengzhengliu angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT ningzhengdong angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT yingxu angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT yunzhao angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT guoqiangxu angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT peironglu angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT jincailuo angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT qingyuwu angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT karialitalo angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT gouyoungkoh angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT ralfhadams angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
AT yulonghe angiopoietinreceptortie2isrequiredforveinspecificationandmaintenanceviaregulatingcouptfii
_version_ 1721476098327314432
spelling doaj-cfed42cfba284d59971714d7bf2ff36f2021-05-05T00:47:12ZengeLife Sciences Publications LtdeLife2050-084X2016-12-01510.7554/eLife.21032Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFIIMan Chu0Taotao Li1Bin Shen2Xudong Cao3Haoyu Zhong4Luqing Zhang5Fei Zhou6https://orcid.org/0000-0003-1857-8831Wenjuan Ma7Haijuan Jiang8Pancheng Xie9Zhengzheng Liu10Ningzheng Dong11Ying Xu12https://orcid.org/0000-0002-6689-7768Yun Zhao13Guoqiang Xu14Peirong Lu15Jincai Luo16Qingyu Wu17Kari Alitalo18Gou Young Koh19Ralf H Adams20Yulong He21https://orcid.org/0000-0002-0099-3749Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, ChinaCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, ChinaCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China; MOE Key Laboratory for Model Animal and Disease Study, Model Animal Research Institute, Nanjing University, Nanjing, ChinaCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, ChinaCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, ChinaCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China; MOE Key Laboratory for Model Animal and Disease Study, Model Animal Research Institute, Nanjing University, Nanjing, ChinaCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China; MOE Key Laboratory for Model Animal and Disease Study, Model Animal Research Institute, Nanjing University, Nanjing, ChinaCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, ChinaCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, ChinaCam-Su Genomic Resources Center, Soochow University, Suzhou, ChinaCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, ChinaCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China; Jiangsu Institute of Hematology, The First Affiliated Hospital, Soochow University, Suzhou, ChinaCam-Su Genomic Resources Center, Soochow University, Suzhou, ChinaCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China; Jiangsu Institute of Hematology, The First Affiliated Hospital, Soochow University, Suzhou, ChinaCollege of Pharmaceutical Sciences, Soochow University, Suzhou, ChinaThe First Affiliated Hospital, Soochow University, Suzhou, ChinaLaboratory of Vascular Biology, Institute of Molecular Medicine, Peking University, Beijing, ChinaCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China; Jiangsu Institute of Hematology, The First Affiliated Hospital, Soochow University, Suzhou, ChinaWihuri Research Institute and Translational Cancer Biology Center of Excellence, Biomedicum Helsinki University of Helsinki, Helsinki, FinlandCenter for Vascular Research, Institute of Basic Science and Korea Advanced Institute of Science and Technology (KAIST), Daejeon, KoreaMax-Planck-Institute for Molecular Biomedicine, Department of Tissue Morphogenesis, Faculty of Medicine, University of Münster, Münster, GermanyCyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China; Cam-Su Genomic Resources Center, Soochow University, Suzhou, China; Jiangsu Institute of Hematology, The First Affiliated Hospital, Soochow University, Suzhou, China; Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Soochow University, Suzhou, ChinaMechanisms underlying the vein development remain largely unknown. Tie2 signaling mediates endothelial cell (EC) survival and vascular maturation and its activating mutations are linked to venous malformations. Here we show that vein formation are disrupted in mouse skin and mesentery when Tie2 signals are diminished by targeted deletion of Tek either ubiquitously or specifically in embryonic ECs. Postnatal Tie2 attenuation resulted in the degeneration of newly formed veins followed by the formation of haemangioma-like vascular tufts in retina and venous tortuosity. Mechanistically, Tie2 insufficiency compromised venous EC identity, as indicated by a significant decrease of COUP-TFII protein level, a key regulator in venogenesis. Consistently, angiopoietin-1 stimulation increased COUP-TFII in cultured ECs, while Tie2 knockdown or blockade of Tie2 downstream PI3K/Akt pathway reduced COUP-TFII which could be reverted by the proteasome inhibition. Together, our results imply that Tie2 is essential for venous specification and maintenance via Akt mediated stabilization of COUP-TFII.https://elifesciences.org/articles/21032Tie2COUP-TFIIvein specification